<DOC>
	<DOCNO>NCT00010088</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine gemcitabine , leucovorin , fluorouracil treat patient locally advanced metastatic cancer pancreas bile duct .</brief_summary>
	<brief_title>Chemotherapy Treating Patients With Locally Advanced Metastatic Cancer Pancreas Bile Duct</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate , term WHO objectives clinical benefit , patient locally advance metastatic pancreatic biliary adenocarcinoma treat gemcitabine , leucovorin calcium , fluorouracil . II . Determine tolerance regimen patient population . III . Determine survival without disease progression patient treat regimen . IV . Determine overall survival patient treat regimen . OUTLINE : This multicenter study . Patients receive leucovorin calcium IV 2 hour follow fluorouracil IV 24 hour day 1 follow gemcitabine IV 80-150 minute day 2 . Treatment repeat every 2 week minimum 6 course absence disease progression unacceptable toxicity . Patients achieve complete response may continue chemotherapy 1 year . Patients locally advance disease 3 month chemotherapy may receive concurrent radiotherapy chemotherapy 5 week , may undergo surgical resection . Fluorouracil-based chemotherapy ( without radiotherapy ) may resume surgery . Patients follow survival . PROJECTED ACCRUAL : A total 14-39 patient accrue study .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Bile Duct Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm pancreatic biliary duct adenocarcinoma Metastatic locally advance No cerebral metastasis Surgically unresectable PATIENT CHARACTERISTICS : Age : 18 75 Performance status : ECOG 02 Life expectancy : More 12 month Hematopoietic : Absolute neutrophil count great 1,500/mm3 Platelet count great 100,000/mm3 Hepatic : Alkaline phosphatase less 5 time normal Bilirubin le 1.5 time normal Renal : Creatinine le 1.5 time normal No uncontrolled persistent hypercalcemia Cardiovascular : No severe cardiac failure Pulmonary : No severe respiratory failure Other : No malignant tumor consider incurable untreatable No uncontrolled pain No psychological , familial , social , geographical reason would preclude study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : No concurrent corticosteroid except antiemetic Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>unresectable extrahepatic bile duct cancer</keyword>
	<keyword>adenocarcinoma extrahepatic bile duct</keyword>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>